Last reviewed · How we verify
Autologous Platelet Concentrates
At a glance
| Generic name | Autologous Platelet Concentrates |
|---|---|
| Also known as | Advanced Platelet-Rich Fibrin (A-PRF+), Concentrated Growth Factors (CGF) |
| Sponsor | Medical Innovation Center Wroclaw |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients (NA)
- Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers (EARLY_PHASE1)
- Healing of Mandibular Third Molar Extraction Sockets Using Platelet Concentrates and Photobiomodulation (NA)
- Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis
- Study on the Use of a Concentrated Growth Factor Preparation Kit for the Treatment of Knee Osteoarthritis (NA)
- Efficacy of the Entire Papilla Preservation Technique With and Without the Use of L-PRF as a Regenerative Material for the Treatment of Infrabony Defects (NA)
- Alveolar Socket Healing With and Without PRGF (NA)
- Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous Platelet Concentrates CI brief — competitive landscape report
- Autologous Platelet Concentrates updates RSS · CI watch RSS
- Medical Innovation Center Wroclaw portfolio CI